1.VEGF mobilizes endothelial progenitor cells to attenuate brain infarction in middle cerebral artery occlusion/reperfusion mice
Ruirui YANG ; Peng XIE ; Yan CHENG
Journal of Third Military Medical University 2003;0(07):-
Objective To observe the change of the number of endothelial progenitor cells(EPCs)in peripheral circulation after acute middle cerebral artery occlusion/reperfusion(MCAO/R)and to evaluate the therapeutic effect of VEGF through mobilizing bone marrow-derived EPCs in treatment of mouse brain infarction after acute MCAO/R.MethodsTotally 36 mice were randomized into MCAO/R+VEGF group,MCAO/R group and sham operation group.MCAO/R mice model was established according Longa's method.VEGF [3.3 ng/(g?d),for 7 d] was injected intraperitoneally to the mice of MCAO/R+VEGF group to mobilize bone marrow-derived EPCs.The other 2 group received an injection of normal saline.At days 1,4,7 during mobilization,neurological functions were evaluated and blood samples were taken from angular vein.Then the number of EPCs in peripheral circulation in MCAO/R group and MCAO/R+VEGF group was detected by flow cytometry.Mice were decapitated and brains sliced and stained with triphenyltetrazolium chloride(TTC)to calculate infarct volume using specific image analyzing system.Infarct volumes were calculated and compared among groups.ResultsThe number of EPCs in MCAO/R+VEGF group began to increase at day 1 after treatment,and peaked at day 4 and sustained to day 7,which was significantly larger than those in MCAO/R group and sham operation group at every time point(P
2.Prevalence of dyslipidemia among adults in Moyu County
Juan YANG ; Xiaoxiao LI ; Ruirui CHENG ; Jinhui ZHUGE ; Wuzimu Jigeer ; Hua YAO ; Mingchen ZHANG
Journal of Preventive Medicine 2022;34(6):590-594
Objective:
To investigate the prevalence of dyslipidemia among adults in Moyu County, Hotan Prefecture, Xinjiang Uygur Autonomous Region, so as to provide insights into the management of dyslipidemia.
Methods:
The physical examination data of permanent residents at ages of 18 years and older were collected from Moyu County from 2018 to 2019, including demographic features, height, body weight, blood pressure and blood biochemical parameter measurements. The epidemiological characteristics of dyslipidemia were analyzed among residents.
Results:
Totally 166 142 adults were investigated, with a mean age of (41.08±15.72) years. There were 77 744 men (46.76%), 34 728 obese adults (20.90%), 5 776 adults with diabetes (3.48%) and 26 294 adults with hypertension (15.83%). The levels of triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were (1.38±0.98), (4.13±1.19), (1.31±0.41) and (2.25±0.77) mmol/L, respectively. The prevalence of dyslipidemia was 29.72%, and the detection rates of high TG, high TC, low-HDL-C and high LDL-C were 9.73%, 4.59%, 19.65% and 1.99%, respectively. The prevalence of dyslipidemia was higher in men than in women (33.97% vs. 25.98%; χ2=1 264.729, P<0.001), and the prevalence increased with age (χ2=539.382, P<0.001) and body mass index (χ2=3 601.833, P<0.001). The prevalence of dyslipidemia was 35.48% among patients with hypertension (χ2=497.251, P<0.001) and 46.07% among patients with diabetes (χ2=766.142, P<0.001). There were 9 059 adults with two and more abnormal blood lipid indexes (18.35%), and the detection rates of two and more abnormal blood lipid indexes were 26.50%, 24.14% and 33.15% among patients with obesity, hypertension and diabetes, respectively.
Conclusions
The prevalence of dyslipidemia among adults in Moyu County is lower than the national level, and low-HDL cholesterolemia is the most common type of dyslipidemia. The prevalence of dyslipidemia is high among patients with obesity, hypertension and diabetes mellitus, in whom abnormality of multiple blood lipid indexes is measured.
3.Current situation and influencing factors of knowledge-attitude-practice of pelvic floor muscle training in women with postpartum stress urinary incontinence
Huan CHENG ; Ruirui GU ; Liping WU
Chinese Journal of Modern Nursing 2021;27(9):1185-1189
Objective:To explore the knowledge-attitude-practice of pelvic floor muscle training in women with postpartum stress urinary incontinence (SUI) .Methods:From January 2018 to January 2019, we conveniently selected 213 patients in the Pelvic Floor Clinic of a Obstetrics and Gynecology Hospital in Beijing 12 weeks after delivery. We used the Pelvic Floor Muscle Function Training Knowledge-Attitude-Practice and Its Needs in Puerperium Women Questionnaire for investigation, and analyzed the influencing factors of knowledge-attitude-behavior of patients' pelvic floor muscle function training.Results:Among 213 SUI patients, the overall standard score of pelvic floor muscle training knowledge-attitude-practice was (75.70±10.23) . Univariate analysis showed that there were statistical differences in the knowledge-attitude-practice of pelvic floor muscle function training among patients with different age, family monthly income per capita, highest education level, occupational status, delivery method, weight gain during pregnancy, and current urinary incontinence ( P<0.2) .Multiple regression analysis showed that family monthly in comeper capita, weight gain during pregnancy, and current urinary incontinence were the influencing factors of pelvic floor muscle function training knowledge-attitude-practice with a statistical difference ( P<0.05) . Conclusions:Postpartum SUI patients have a positive attitude towards pelvic floor muscle function training, but their cognitive level needs to be improved. Medical and nursing staff should strengthen the publicity and education of relevant knowledge, and enhance patients' awareness of the importance of pelvic floor muscle function training.
4.Analysis of outcomes and prognostic factors in 307 stages Ⅱ-Ⅲ esophageal cancer patients treated with concurrent chemoradiotherapy
Xinyu CHENG ; Hui WU ; Ruirui ZHANG ; Xueming SUN ; Zhumin YAN ; Xiao LIU ; Yongshun CHEN
Chinese Journal of Radiation Oncology 2018;27(2):140-144
Objective To summarize the outcomes and prognostic factors in esophageal cancer (EC) patients.Methods A total of 307 EC patients of stages Ⅱ-Ⅲ were treated with concurrent chemoradiotherapy in our hospital from September 2006 to July 2014.There were 73 patients with stage Ⅱ and 234 with stage Ⅲ.The radiotherapy dose was 50-70 Gy (median 60 Gy).Concurrent chemoradiotherapy were used with fluorouracil plus platinum (PF,166),paclitaxel plus platinum (TP,82) or platinum only (P,59).The Kaplan-Meier method was used to calculate overall survival (OS) and progression-free survival (PFS) rates,the log-rank test was used for survival difference analysis and univariate prognostic analysis.The Cox regression model was used for multivariate prognostic analysis.Results The 1-,3-5-year OS and PFS rates were85.6%,53.8%,36.9% and 74.6%,43.7%,33.1%,respectively.The median OS and PFS were 41.6 months and 29.8 months.The univariate analysis indicated that T stage,N stage,clinical stage,lesion location,lesion length and chemotherapy regimen were prognostic factors for OS and PFS (P=0.007 and 0.013,0.000 and 0.000,0.000 and 0.000,0.002 and 0.000,0.141 and 0.005,0.018 and 0.165).Multivariate analysis showed that T stage,N stage,lesion location and chemotherapy regimen were prognostic factors for OS (P =0.024,0.000,0.007 and 0.028),lesion location,lesion length and N stage were prognostic factors for PFS (P=0.004,0.033 and 0.035).The median OS and PFS for EC patients treated by total dose 50-60 Gy,>60-70 Gy were 47.4 months,37.8 months (P=0.469) and34.1 months,25.1 months (P=0.0.233),therewere no statistic difference.Conclusions The outcome of EC patients treated with concurrent chemoratherapy could obtain a long-term survival,combination chemotherapy is superior to single drug,there are no statistical difference between high-dose and low-dose,and the acute toxic effects can be tolerated.
5.Nucleomodulin BspJ as an effector promotes the colonization of Brucella abortus in the host
Zhongchen MA ; Shuifa YU ; Kejian CHENG ; Yuhe MIAO ; Yimei XU ; Ruirui HU ; Wei ZHENG ; Jihai YI ; Huan ZHANG ; Ruirui LI ; Zhiqiang LI ; Yong WANG ; Chuangfu CHEN
Journal of Veterinary Science 2022;23(1):e8-
Background:
Brucella infection induces brucellosis, a zoonotic disease. The intracellular circulation process and virulence of Brucella mainly depend on its type IV secretion system (T4SS) expressing secretory effectors. Secreted protein BspJ is a nucleomodulin of Brucella that invades the host cell nucleus. BspJ mediates host energy synthesis and apoptosis through interaction with proteins. However, the mechanism of BspJ as it affects the intracellular survival of Brucella remains to be clarified.
Objectives:
To verify the functions of nucleomodulin BspJ in Brucella's intracellular infection cycles.
Methods:
Constructed Brucella abortus BspJ gene deletion strain (B. abortus ΔBspJ) and complement strain (B. abortus pBspJ) and studied their roles in the proliferation of Brucella both in vivo and in vitro.
Results:
BspJ gene deletion reduced the survival and intracellular proliferation of Brucellaat the replicating Brucella-containing vacuoles (rBCV) stage. Compared with the parent strain, the colonization ability of the bacteria in mice was significantly reduced, causing less inflammatory infiltration and pathological damage. We also found that the knockout of BspJ altered the secretion of cytokines (interleukin [IL]-6, IL-1β, IL-10, tumor necrosis factor-α, interferon-γ) in host cells and in mice to affect the intracellular survival of Brucella.
Conclusions
BspJ is extremely important for the circulatory proliferation of Brucella in the host, and it may be involved in a previously unknown mechanism of Brucella's intracellular survival.
6.Analysis of gene variant in a Chinese pedigree with preaxial polydactyly.
Zhe LI ; Yongan ZHOU ; Jianwei LI ; Junmei GENG ; Xingxing LI ; Yuan BAI ; Yaxin HAN ; Jianping CHENG ; Yanhong QIN ; Ruirui REN
Chinese Journal of Medical Genetics 2021;38(11):1106-1109
OBJECTIVE:
To analyze the pathogenic variant of preaxial polydactyly in a Chinese Han pedigree and identify the cause of polydactyly.
METHODS:
The peripheral blood DNA of the proband and her parents was extracted. The polydactyly-related genes were detected by trio whole exome sequencing, and the suspected pathogenic gene was screened out. Sanger sequencing was applied to other members of the pedigree.
RESULTS:
The results of gene sequencing showed that the LMBR1 gene had a heterozygous variant of c.423+4909(IVS5)C>T in 6 patients of the pedigree. The same variant was not detected in family members with normal phenotype. Based on the ACMG guidelines, c.423+4909(IVS5)C>T of the LMBR1 gene was predicted to be pathogenic (PM1+PM2+PP1-S(PS)+PP4+PP5).
CONCLUSION
The heterozygous C>T variant at position 4909 of intron 5 of the LMBR1 gene probably underlies the disease in this pedigree.
China
;
Female
;
Humans
;
Mutation
;
Pedigree
;
Polydactyly/genetics*
;
Thumb
;
Whole Exome Sequencing
7.Identification of a novel SOD1 variant in a Chinese patient with amyotrophic lateral sclerosis.
Yuan BAI ; Yong'an ZHOU ; Jianwei LI ; Junmei GENG ; Xingxing LI ; Zhe LI ; Jianping CHENG ; Yaxin HAN ; Ruirui REN
Chinese Journal of Medical Genetics 2021;38(12):1224-1227
OBJECTIVE:
To explore the genetic basis for a Chinese patient with amyotrophic lateral sclerosis (ALS).
METHODS:
Peripheral blood samples were collected from the patient and his parents for the extraction of genomic DNA. Genetic variant was identified by whole exome sequencing. Candidate variant was verified by Sanger sequencing of his parents and healthy controls.
RESULTS:
The patient was found to harbor a heterozygous c.420C>G (p.Asn140Lys) variant of the SOD1 gene. The same variant was not detected in his parents and 100 healthy controls. The variant has not been included in HGMD, dbSNP and other databases.
CONCLUSION
The c.420C>G variant of the SOD1 gene may underlie the ALS in this patient. Above finding has enriched the spectrum of SOD1 gene variants.
Amyotrophic Lateral Sclerosis/genetics*
;
China
;
Heterozygote
;
Humans
;
Superoxide Dismutase-1/genetics*
;
Whole Exome Sequencing
8.Analysis of PKD2 gene variant and protein localization in a pedigree affected with polycystic kidney disease.
Jianping CHENG ; Ping LI ; Yujun LI ; Yong'an ZHOU ; Ruirui REN ; Yaxin HAN ; Xingxing LI ; Zhe LI ; Yuan BAI
Chinese Journal of Medical Genetics 2021;38(1):47-51
OBJECTIVE:
To detect the mutation site in a pedigree affected with autosomal dominant polycystic kidney disease (ADPKD) and verify its impact on the protein function.
METHODS:
Peripheral blood samples were collected from the proband and his pedigree members for the extraction of genomic DNA. Mutational analysis was performed on the proband through whole-exome sequencing. Suspected variant was verified by Sanger sequencing. A series of molecular methods including PCR amplification, restriction enzyme digestion, ligation and transformation were also used to construct wild-type and mutant eukaryotic expression vectors of the PKD2 gene, which were transfected into HEK293T and HeLa cells for the observation of protein expression and cell localization.
RESULTS:
The proband was found to harbor a c.2051dupA (p. Tyr684Ter) frame shift mutation of the PKD2 gene, which caused repeat of the 2051st nucleotide of its cDNA sequence and a truncated protein. Immunofluorescence experiment showed that the localization of the mutant protein within the cell was altered compared with the wild-type, which may be due to deletion of the C-terminus of the PKD2 gene.
CONCLUSION
The c.2051dupA (p. Tyr684Ter) mutation of the PKD2 gene probably underlay the pathogenesis of ADPKD in this pedigree.
DNA Mutational Analysis
;
Female
;
Frameshift Mutation
;
HEK293 Cells
;
HeLa Cells
;
Humans
;
Male
;
Pedigree
;
Polycystic Kidney, Autosomal Dominant/physiopathology*
;
Protein Kinases/genetics*
;
Protein Transport/genetics*
;
Whole Exome Sequencing
9.Therapeutic effect of nivolumab on non-small-cell lung cancer patients with brain metastases: a retrospective study
Guowei ZHANG ; Ruirui CHENG ; Huijuan WANG ; Yong ZHANG ; Peng LI ; Xiangtao YAN ; Mina ZHANG ; Xiaojuan ZHANG ; Jinpo YANG ; Zhiyong MA
Chinese Journal of Oncology 2020;42(11):961-965
Objective:To preliminarily explore the treatment effect of nivolumab on Chinese non-small-cell lung cancer (NSCLC) patients with brain metastases, and further enrich the evidences of programmed death-ligand 1 (PD-1) monoclonal antibody in the treatment of NSCLC patients with brain metastases.Methods:The clinical and pathological data of 22 NSCLC patients with brain metastases treated with nivolumab were collected. The electronic imaging data were collected to confirm the treatment effect and time point of disease progression, and the survival data of the patients were obtained through follow-up.Results:Twenty-one patients were evaluated for the intracranial treatment effect. The intracerebral objective response rate (IORR) was 28.6%, the intracranial disease control rate (IDCR) was 47.6%. The median intracranial progression-free-survival (iPFS) of all the 22 patients was 5.2 months. Both the 1-year and 2-year survival rates were 56.7%.Conclusions:The treatment effect of PD-1 monoclonal antibody on NSCLC patients with brain metastases is similar as those without brain metastases.
10.Therapeutic effect of nivolumab on non-small-cell lung cancer patients with brain metastases: a retrospective study
Guowei ZHANG ; Ruirui CHENG ; Huijuan WANG ; Yong ZHANG ; Peng LI ; Xiangtao YAN ; Mina ZHANG ; Xiaojuan ZHANG ; Jinpo YANG ; Zhiyong MA
Chinese Journal of Oncology 2020;42(11):961-965
Objective:To preliminarily explore the treatment effect of nivolumab on Chinese non-small-cell lung cancer (NSCLC) patients with brain metastases, and further enrich the evidences of programmed death-ligand 1 (PD-1) monoclonal antibody in the treatment of NSCLC patients with brain metastases.Methods:The clinical and pathological data of 22 NSCLC patients with brain metastases treated with nivolumab were collected. The electronic imaging data were collected to confirm the treatment effect and time point of disease progression, and the survival data of the patients were obtained through follow-up.Results:Twenty-one patients were evaluated for the intracranial treatment effect. The intracerebral objective response rate (IORR) was 28.6%, the intracranial disease control rate (IDCR) was 47.6%. The median intracranial progression-free-survival (iPFS) of all the 22 patients was 5.2 months. Both the 1-year and 2-year survival rates were 56.7%.Conclusions:The treatment effect of PD-1 monoclonal antibody on NSCLC patients with brain metastases is similar as those without brain metastases.